Jacobio Pharmaceuticals Group Co LtdJacobio Pharmaceuticals Group Co Ltd - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

Jump to the end of this page for potential risks for Jacobio Pharmaceuticals Group Co Ltd based on sector, geography and size. Alternative companies in the rating peer group for Jacobio Pharmaceuticals Group Co Ltd are displayed below. The page displays a free Environmental, Social and Governance analysis for Jacobio Pharmaceuticals Group Co Ltd.

Jacobio Pharmaceuticals Group Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.5; made up of an environmental score of 3.2, social score of 1.6 and governance score of 2.7.

SDG Transparency Score for Jacobio Pharmaceuticals Group Co Ltd 

2.5

Low Impact
0 - 3
Medium
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Jacobio Pharmaceuticals Group Co Ltd 
3.2

Environmental

1.6

Social

2.7

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
.........
1954Vaxcell Bio Therapeutics
2.6
Medium
1954Zhejiang Starry Pharmaceutical Co Ltd
2.6
Medium
1976Jacobio Pharmaceuticals Group Co Ltd
2.5
Medium
1976Chemon Inc
2.5
Medium
1976Chengdu Kanghong Pharmaceutical Group Co Ltd
2.5
Medium
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Jacobio Pharmaceuticals Group Co Ltd have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Jacobio Pharmaceuticals Group Co Ltd disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Jacobio Pharmaceuticals Group Co Ltd report the average age of the workforce?

LockedSign up for free to unlock

Does Jacobio Pharmaceuticals Group Co Ltd reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Jacobio Pharmaceuticals Group Co Ltd disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Jacobio Pharmaceuticals Group Co Ltd disclose cybersecurity risks?

LockedSign up for free to unlock

Does Jacobio Pharmaceuticals Group Co Ltd offer flexible work?

LockedSign up for free to unlock

Does Jacobio Pharmaceuticals Group Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Jacobio Pharmaceuticals Group Co Ltd disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Jacobio Pharmaceuticals Group Co Ltd conduct supply chain audits?

LockedSign up for free to unlock

Does Jacobio Pharmaceuticals Group Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Jacobio Pharmaceuticals Group Co Ltd conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Jacobio Pharmaceuticals Group Co Ltd disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Jacobio Pharmaceuticals Group Co Ltd disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Jacobio Pharmaceuticals Group Co Ltd disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Jacobio Pharmaceuticals Group Co Ltd disclose water use targets?

LockedSign up for free to unlock

Does Jacobio Pharmaceuticals Group Co Ltd have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Jacobio Pharmaceuticals Group Co Ltd have a product recall in the last two years?

LockedSign up for free to unlock

Does Jacobio Pharmaceuticals Group Co Ltd disclose incidents of discrimination?

LockedSign up for free to unlock

Does Jacobio Pharmaceuticals Group Co Ltd allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Jacobio Pharmaceuticals Group Co Ltd issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Jacobio Pharmaceuticals Group Co Ltd disclose parental leave metrics?

LockedSign up for free to unlock

Does Jacobio Pharmaceuticals Group Co Ltd disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Jacobio Pharmaceuticals Group Co Ltd disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Jacobio Pharmaceuticals Group Co Ltd disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Jacobio Pharmaceuticals Group Co Ltd support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Jacobio Pharmaceuticals Group Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Jacobio Pharmaceuticals Group Co Ltd reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Jacobio Pharmaceuticals Group Co Ltd involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Jacobio Pharmaceuticals Group Co Ltd disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Jacobio Pharmaceuticals Group Co Ltd disclose its waste policy?

LockedSign up for free to unlock

Does Jacobio Pharmaceuticals Group Co Ltd report according to TCFD requirements?

LockedSign up for free to unlock

Does Jacobio Pharmaceuticals Group Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Jacobio Pharmaceuticals Group Co Ltd disclose energy use targets?

LockedSign up for free to unlock

Does Jacobio Pharmaceuticals Group Co Ltd disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Jacobio Pharmaceuticals Group Co Ltd have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Jacobio Pharmaceuticals Group Co Ltd
These potential risks are based on the size, segment and geographies of the company.

Jacobio Pharmaceuticals Co., Ltd., a clinical-stage pharmaceutical company, focusing on the in-house discovery and development of oncology therapies. The company's lead drug development programs include two clinical-stage allosteric SHP2 inhibitors comprising JAB-3068 and JAB-3312 for the treatment of esophageal cancer; JAB-8263, a small molecule inhibitor of BET family proteins regulating MYC transcription to treat various cancers; and JAB-21822, an oral small molecule targeting mutant KRAS G12C protein. It is also developing JAB-BX102, a humanized inhibitory antibody against human CD73 for the treatment of PD-1 resistant cancer; JAB-6343, an inhibitor that targets fibroblast growth factor receptor 4 for advanced hepatocellular carcinoma with FGF19 overexpression; JAB-2485, an aurora A kinase inhibitor to treat various RB1-deficient tumors; JAB-24000, a tumor metabolic pathway for the treatment of solid tumors; and JAB-BX300, a molecule antibody targeting RAS pathway to treat pancreatic and other solid tumors with KRAS mutations. The company has a strategic collaboration with AbbVie Ireland Unlimited Company to develop and commercialize SHP2 inhibitors. Jacobio Pharmaceuticals Co., Ltd. was incorporated in 2015 and is headquartered in Beijing, China.

Sorry!

Failed to process!